Meeting for New Zealand manufacturers of prescription and non-prescription medicines, complementary medicines and medical devices
New Zealand manufacturers of prescription and non-prescription medicines, complementary medicines and medical devices are invited to attend a focus meeting about the manufacturing aspects of the proposed regulatory scheme to be administered by the ANZTPA.
Staff of New Zealand's Medsafe and the Australian Therapeutic Goods Administration will present information about the proposed regulatory scheme and what it will mean for New Zealand manufacturers.
The information session will cover:
- The proposed structure for GMP in the ANZTPA
- Improvements in the GMP interface with industry
- Proposed fees for audit and licensing of manufacturers
- The consultation process, including next steps
The meeting will be held from 2pm to 4pm on 9 June 2006 at the Aotea Centre, ASB Theatre, Queen Street, Auckland.
If you are a New Zealand manufacturer and would like to attend this information session please contact the ANZTPA Establishment Project Team: donna_fong@moh.govt.nz to register your attendance by 27 May 2006.
This meeting session is in addition to the series of stakeholder information sessions about the Australia New Zealand Therapeutic Products Authority (ANZTPA) and the proposed regulatory scheme for therapeutic products being held in New Zealand and Australia during June.
Further information about the meeting schedule can be found on this website.